Ask a doctor about a prescription for FLUCONAZOLE AUROVITAS 100 mg HARD CAPSULES
Package Leaflet: Information for the User
Fluconazole Aurovitas 50 mg hard capsules EFG
Fluconazole Aurovitas 100 mg hard capsules EFG
Fluconazole Aurovitas 150 mg hard capsules EFG
Fluconazole Aurovitas 200 mg hard capsules EFG
fluconazole
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
This medicine is one of a group of medicines called “antifungals”. The active substance is fluconazole.
This medicine is used to treat infections caused by fungi, and it can also be used to prevent the appearance of candidiasis. The most common cause of fungal infections is a yeast called Candida.
Adults
Your doctor may prescribe this medicine to treat the following types of fungal infections:
It may also be prescribed for you to:
Children and adolescents (0 to 17 years)
Your doctor may prescribe this medicine to treat the following types of fungal infections:
It may also be prescribed for you to:
Do not take Fluconazole Aurovitas:
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medicine.
Severe skin reactions, including drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported in relation to fluconazole treatment. Stop taking fluconazole and seek immediate medical attention if you notice any of the symptoms related to these severe skin reactions described in section 4.
Talk to your doctor or pharmacist if the fungal infection does not improve, it may be necessary to use an alternative antifungal treatment.
Other medicines and Fluconazole Aurovitas
Immediatelyinform your doctor if you are taking astemizole, terfenadine (an antihistamine for treating allergies), cisapride (used for stomach upset), pimozide (used for treating mental illnesses), quinidine (used for treating heart arrhythmias) or erythromycin (an antibiotic for treating infections), as these medicines should not be taken with this medicine (see section: “Do not take Fluconazole Aurovitas”).
There are some medicines that may interact with this medicine. Make sure your doctor knows if you are taking any of the following medicines, as it may be necessary to adjust the dose or monitor to check that the medicines are still having the desired effect:
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
Taking Fluconazole Aurovitas with food, drinks and alcohol
You can take the medicine with or without food.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
If you are planning to become pregnant, it is recommended that you wait one week after a single dose of fluconazole before becoming pregnant.
For longer cycles of fluconazole treatment, consult your doctor about the need to use adequate contraceptive methods during treatment, which should be maintained for one week after the last dose.
Do not take Fluconazole Aurovitas if you are pregnant, think you may be pregnant or are planning to have a baby, or are breast-feeding, unless your doctor has told you to. If you become pregnant while taking this medicine or in the week following the last dose, consult your doctor.
Fluconazole taken during the first or second trimester of pregnancy may increase the risk of spontaneous abortion. Fluconazole taken during the first trimester may increase the risk of a baby being born with congenital anomalies affecting the heart, bones and/or muscles.
Cases of babies born with congenital anomalies affecting the skull, ears and bones of the thigh and elbow have been reported in women treated for three months or more with high doses (400-800 mg daily) of fluconazole for coccidioidomycosis. The relationship between fluconazole and these cases is unclear.
You can continue breast-feeding after taking a single dose of 150 mg of this medicine.
Do not continue breast-feeding if you are taking repeated doses of this medicine.
Driving and using machines
When driving or operating machinery, you should take into account that dizziness or seizures may occasionally occur.
Fluconazole Aurovitas contains lactose monohydrate,a type of sugar.If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.
Fluconazole Aurovitas contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per hard capsule, which is essentially “sodium-free”.
Follow the instructions for use of this medicine exactly as indicated by your doctor or pharmacist.
In case of doubt, consult your doctor or pharmacist again.
The capsules should be swallowed whole with the help of a glass of water. It is best to take your capsules always at the same time of day.
Instructions for removing the capsule from the blister cavity:
Pressing the capsule cavity in the central part may cause deformations/breakages of the capsule as shown in figure A. To avoid such damage to the capsule, press the capsule cavity at one end to remove it from the blister as shown in figure B.
Fig. AFig. B
The following is the recommended dose of this medicine for the different types of infections:
Adults
Condition | Dose |
For treating cryptococcal meningitis | 400 mg on the first day and then 200 mg to 400 mg once a day for 6 to 8 weeks or longer if necessary. Sometimes the dose is increased to 800 mg |
For preventing the recurrence of cryptococcal meningitis | 200 mg once a day until your doctor tells you to |
For treating coccidioidomycosis | 200 mg to 400 mg once a day from 11 months to 24 months or longer if necessary. Sometimes the dose is increased to 800 mg |
For treating internal fungal infections caused by Candida | 800 mg on the first day and then 400 mg once a day until your doctor tells you to |
For treating mucosal infections that affect the lining of the mouth, throat or associated with dental prostheses. | 200 mg to 400 mg on the first day and then 100 mg to 200 mg once a day until your doctor tells you to |
For treating mucosal candidiasis – the dose depends on where the infection is located | 50 mg to 400 mg once a day for 7 to 30 days until your doctor tells you to |
For preventing the recurrence of mucosal infections that affect the lining of the mouth and throat | 100 mg to 200 mg once a day, or 200 mg 3 times a week, while the risk of developing an infection continues |
For treating genital candidiasis | 150 mg in a single dose |
For reducing the repeated appearance of vaginal infections | 150 mg every 3 days for a total of 3 doses (day 1, 4 and 7) and then once a week for 6 months while the risk of developing an infection continues |
For treating fungal skin or nail infections | Depending on the location of the infection 50 mg once a day, 150 mg once a week, 300 to 400 mg once a week for 1 to 4 weeks (for athlete's foot, up to 6 weeks may be necessary, for nail infections, treatment should continue until a healthy nail grows) |
For preventing the spread of Candidainfection (if your immune system is weak and not working properly) | 200 mg to 400 mg once a day while the risk of developing an infection continues |
Use in children and adolescents
Adolescents from 12 to 17 years of age
Follow the dose indicated by your doctor (the adult posology or the pediatric posology).
Children up to 11 years
The maximum daily dose for children is 400 mg per day.
The dose will be based on the child's weight in kilograms.
Condition | Daily dose |
Mucosal candidiasis and throat infections caused by Candida– the dose and duration of treatment depend on the severity of the infection and where it is located. | 3 mg per kg of body weight once a day (on the first day, 6 mg per kg of body weight may be given) |
Cryptococcal meningitis or internal fungal infections caused by Candida | 6 mg to 12 mg per kg of body weight once a day |
For preventing the recurrence of cryptococcal meningitis | 6 mg per kg of body weight once a day |
For preventing the child from contracting a Candidainfection (if their immune system is not working properly) | 3 mg to 12 mg per kg of body weight once a day |
Use in children from 0 to 4 weeks of age
Use in children from 3 to 4 weeks of age:
The same dose as described in the table, but administered once every 2 days. The maximum dose is 12 mg per kg of body weight every 48 hours.
Use in children under 2 weeks of age:
The same dose as described in the table, but administered once every 3 days. The maximum dose is 12 mg per kg of body weight every 72 hours.
Elderly patients
The usual adult dose, unless you have kidney problems.
Patients with kidney problems
Your doctor may change your dose, depending on how well your kidneys are working.
If you take more Fluconazole Aurovitas than you should
Taking too many capsules at once can make you feel unwell. In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone: 91 562 04 20, indicating the medicine and the amount taken. It is recommended to take the package and the leaflet of the medicine to the healthcare professional.
The symptoms of a possible overdose may include hearing, seeing, feeling and thinking things that are not real (hallucinations and paranoid behavior). It may be appropriate to initiate symptomatic treatment (with supportive measures and stomach lavage if necessary).
If you forget to take Fluconazole Aurovitas
Do not take a double dose to make up for forgotten doses. If you have forgotten to take a dose, take it as soon as you remember. If it is almost time for the next dose, do not take the forgotten dose.
If you have any doubts about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. Stop taking Fluconazol Aurovitas and seek immediate medical attention if you notice any of the following symptoms:
Some people develop allergic reactions, although severe allergic reactions are rare.If any of the following adverse effects appear, talk to your doctor or pharmacist. This includes possible adverse effects not mentioned in this leaflet. If you suffer from any of the following adverse effects, inform your doctor or pharmacist immediately:
This medicine may affect your liver. Signs that indicate liver problems include:
If you experience any of these symptoms, stop taking this medicine and inform your doctor immediately.
Other Adverse Effects:
Additionally, if you consider that any of the adverse effects you are experiencing are serious or if you notice any adverse effect not mentioned in this leaflet, inform your doctor or pharmacist.
Common adverse effects (may affect up to 1 in 10 people):
Uncommon adverse effects (may affect up to 1 in 100 people):
Rare adverse effects (may affect up to 1 in 1,000 people):
Frequency not known but may occur (cannot be estimated from available data):
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not mentioned in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep out of sight and reach of children.
Do not use this medicine after the expiration date stated on the packaging after CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medicines should not be disposed of through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE Point in the pharmacy. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Fluconazol Aurovitas
The composition of the capsules is titanium dioxide (E171), sodium lauryl sulfate, and gelatin.
The printing ink contains shellac and yellow iron oxide (E172).
Appearance of the Product and Package Contents
Fluconazol Aurovitas 50 mg hard capsules EFG
Hard gelatin capsules, white to off-white opaque, size “4”, filled with white to off-white powder, and printed with the letter “FL” on the white to off-white opaque face and with the number “50” on the white to off-white opaque body with yellow ink.
Fluconazol Aurovitas 100 mg hard capsules EFG
Hard gelatin capsules, white to off-white opaque, size “2”, filled with white to off-white powder, and printed with the letter “FL” on the white to off-white opaque face and with the number “100” on the white to off-white opaque body with yellow ink.
Fluconazol Aurovitas 150 mg hard capsules EFG
Hard gelatin capsules, white to off-white opaque, size “1”, filled with white to off-white powder, and printed with the letter “FL” on the white to off-white opaque face and with the number “150” on the white to off-white opaque body with yellow ink.
Fluconazol Aurovitas 200 mg hard capsules EFG
Hard gelatin capsules, white to off-white opaque, size “0”, filled with white to off-white powder, and printed with the letter “FL” on the white to off-white opaque face and with the number “200” on the white to off-white opaque body with yellow ink.
Fluconazol Aurovitas hard capsules are available in PVC/PVDC-Aluminum blisters
Packaging sizes: 1, 2, 3, 4, 6, 7, 10, 12, 14, 20, 28, 30, 42, 50, 60, 100, and 500 hard capsules
Not all packaging sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Aurovitas Spain, S.A.U.
Avda. De Burgos, 16-D
28036 Madrid
Spain.
Manufacturer:
APL Swift Services (Malta) Ltd
HF26, Hal Far Industrial Estate, Hal Far
Birzebbugia, BBG 3000
Malta
or
Generis Farmaceutica, S.A.
Rua João de Deus, n. o 19, Venda Nova
2700-487, Amadora
Portugal
This medicine is authorized in the Member States of the European Economic Area under the following names:
Belgium: Fluconazol AB 50 mg/100 mg/150 mg/200 mg hard capsules
Luxembourg: Fluconazol AB 50 mg/100 mg/150 mg/200 mg hard capsules
Poland: Fluconazole Aurovitas
Portugal: Fluconazol Ritisca
Spain: Fluconazol Aurovitas 50 mg/100 mg/150 mg/200 mg hard capsules EFG.
Date of the Last Revision of this Leaflet:February 2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es)
The average price of FLUCONAZOLE AUROVITAS 100 mg HARD CAPSULES in October, 2025 is around 15 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for FLUCONAZOLE AUROVITAS 100 mg HARD CAPSULES – subject to medical assessment and local rules.